BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 18096481)

  • 1. Lung transplantation in the management of patients with lymphangioleiomyomatosis: baseline data from the NHLBI LAM Registry.
    Maurer JR; Ryu J; Beck G; Moss J; Lee JC; Finlay G; Brown K; Chapman J; McMahan J; Olson E; Ruoss S; Sherer S;
    J Heart Lung Transplant; 2007 Dec; 26(12):1293-9. PubMed ID: 18096481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting Individualized Lung Disease Progression in Treatment-Naive Patients With Lymphangioleiomyomatosis.
    Palipana AK; Gecili E; Song S; Johnson SR; Szczesniak RD; Gupta N
    Chest; 2023 Jun; 163(6):1458-1470. PubMed ID: 36610667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum vascular endothelial growth factor-D as a diagnostic and therapeutic biomarker for lymphangioleiomyomatosis.
    Hirose M; Matsumuro A; Arai T; Sugimoto C; Akira M; Kitaichi M; Young LR; McCormack FX; Inoue Y
    PLoS One; 2019; 14(2):e0212776. PubMed ID: 30818375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphangioleiomyomatosis: circulating levels of FGF23 and pulmonary diffusion.
    Esposito AJ; Imani J; Shrestha S; Bagwe S; Lamattina AM; Vivero M; Goldberg HJ; Rosas IO; Henske EP; El-Chemaly SY
    J Bras Pneumol; 2023; 49(2):e20220356. PubMed ID: 37132737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Childhood interstitial lung disease in Turkey: first data from the national registry.
    Nayır-Büyükşahin H; Emiralioğlu N; Kılınç AA; Girit S; Yalçın E; Şişmanlar Eyüboğlu T; Çobanoğlu N; Cinel G; Pekcan S; Gökdemir Y; Oğuz B; Orhan D; Doğru D; Özçelik U; Başkan AK; Arslan H; Çokuğraş H; Onay ZR; Oksay SC; Tortop DM; Aslan AT; Kekeç H; Zirek F; Tekin MN; Gülen F; Girgin Dindar B; Eryılmaz Polat S; Uytun S; Yılmaz Aİ; Ünal G; Eralp EE; Karadağ B; Hangül M; Köse M; Özsezen B; Çakır E; Bingöl A; Hızal M; Kartal Öztürk G; Uyan ZS; Ramaslı Gürsoy T; Serbes M; Kiper N
    Eur J Pediatr; 2024 Jan; 183(1):295-304. PubMed ID: 37875631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy in lymphangioleiomyomatosis: clinical and lung function outcomes in two national cohorts.
    Taveira-DaSilva AM; Johnson SR; Julien-Williams P; Johnson J; Stylianou M; Moss J
    Thorax; 2020 Oct; 75(10):904-907. PubMed ID: 32788260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphangioleiomyomatosis and tuberous sclerosis complex.
    Chorianopoulos D; Stratakos G
    Lung; 2008; 186(4):197-207. PubMed ID: 18408969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphangioleiomyomatosis: a clinical update.
    McCormack FX
    Chest; 2008 Feb; 133(2):507-16. PubMed ID: 18252917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphangioleiomyomatosis and pregnancy: a mini-review.
    Zhou J; Diao M
    Arch Gynecol Obstet; 2024 Jun; 309(6):2339-2346. PubMed ID: 38594407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuberous sclerosis complex for the pulmonologist.
    Rebaine Y; Nasser M; Girerd B; Leroux C; Cottin V
    Eur Respir Rev; 2021 Sep; 30(161):. PubMed ID: 34348978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated p53 in the anti-apoptotic milieu of tuberous sclerosis gene mutation induced diseases leads to cell death if thioredoxin reductase is inhibited.
    Abdelwahab EMM; Bovari-Biri J; Smuk G; Fillinger J; McPhail D; Krymskaya VP; Pongracz JE
    Apoptosis; 2021 Jun; 26(5-6):253-260. PubMed ID: 33860865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Retrospective Study of Lung Transplantation in Patients With Lymphangioleiomyomatosis: Challenges and Outcomes.
    Zhang J; Liu D; Yue B; Ban L; Zhou M; Wang H; Lv J; Wu B; Zhai Z; Xu KF; Chen W; Chen J
    Front Med (Lausanne); 2021; 8():584826. PubMed ID: 33665195
    [No Abstract]   [Full Text] [Related]  

  • 13. Pregnancy unmasking symptoms of undiagnosed lymphangioleiomyomatosis: Case report and review of literature.
    Khaddour K; Shayuk M; Ludhwani D; Gowda S; Ward WL
    Respir Med Case Rep; 2019; 26():63-67. PubMed ID: 30555778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the priorities for women diagnosed with lymphangioleiomyomatosis: a patient perspective.
    Bassi I; Hollis G; Cottin V; Harari S; Zwanenburg E; Veltkamp M; Casanova A; Fletcher M; Masefield S; Powell P; Boyd J
    ERJ Open Res; 2016 Apr; 2(2):. PubMed ID: 27730199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrence of lymphangioleiomyomatosis: Nine years after a bilateral lung transplantation.
    Zaki KS; Aryan Z; Mehta AC; Akindipe O; Budev M
    World J Transplant; 2016 Mar; 6(1):249-54. PubMed ID: 27011924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple cystic lung disease.
    Ferreira Francisco FA; Soares Souza A; Zanetti G; Marchiori E
    Eur Respir Rev; 2015 Dec; 24(138):552-64. PubMed ID: 26621970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of lymphangioleiomyomatosis.
    Taveira-DaSilva AM; Moss J
    F1000Prime Rep; 2014; 6():116. PubMed ID: 25580270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffuse cystic lung diseases.
    Ryu JH; Tian X; Baqir M; Xu K
    Front Med; 2013 Sep; 7(3):316-27. PubMed ID: 23666611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is sirolimus a therapeutic option for patients with progressive pulmonary lymphangioleiomyomatosis?
    Neurohr C; Hoffmann AL; Huppmann P; Herrera VA; Ihle F; Leuschner S; von Wulffen W; Meis T; Baezner C; Leuchte H; Baumgartner R; Zimmermann G; Behr J
    Respir Res; 2011 May; 12(1):66. PubMed ID: 21600034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Milestones in lymphangioleiomyomatosis research.
    Cottin V; Archer F; Leroux C; Mornex JF; Cordier JF
    Eur Respir Rev; 2011 Mar; 20(119):3-6. PubMed ID: 21357887
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.